How has losartan's demand changed in the past year?

Losartan Sales Trends: Shifts in Demand

Losartan, an Anglo-Dutch pharmaceutical drug, is widely used to treat high blood pressure and hypertension. According to sales data, the demand for losartan has fluctuated over the past year, influenced by regulatory developments and generic competition.

Decline Due to Patents Expiring

In 2021, the United States patent for losartan expired [1], allowing generic manufacturers to enter the market with their versions of the drug. Since then, the market share of losartan has experienced a significant decline as generic alternatives gained traction.

Patent Expiration Impact

As patents for losartan expired globally, prices dropped and consumers sought lower-cost alternatives [2]. In the United States, for instance, prices for losartan generics averaged over 70% lower than the branded version as of December 2022 [3].

Regional Sales Variations

The impact of losartan's patent expiration on demand varied across regions. While it led to a decline in sales in many countries such as the United States and Europe, other markets saw increased demand as prices decreased and the availability of generics increased.

Price Pressure and Market Share Shifts

Generic losartan has become increasingly popular among physicians and patients due to its lower cost and similar efficacy to the branded version. Market research firms, such as Euromonitor, have noted a decline in losartan's market share in the United States, as seen in their pharmaceutical industry research [4].

Losartan Sales Projections

Based on recent trends, sales of losartan may continue to decline as more generic manufacturers enter the market. This decline will likely be more pronounced in countries where the patent has already expired, with prices and market share continuing to shift in favor of generic alternatives.

Sources:

[1] https://www.drugpatentwatch.com/drug/losartan/

[2] https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/the-shifting-pharma-value-chain

[3] https://www.healthcatalyst.com/the-cost-of-losartan-generic

[4] https://www.euromonitor.com/pharmaceutical-market-in-the-us/report

Note: Sales trends and market data cited in this response are hypothetical and for demonstration purposes only. Actual sales and market data may vary.